Innova
Rx
Innova Health Strategies
Search
Index
Browse
Meds
Risk score
Pricing
Sign in
Code set
FY2027
FY2026
FY2025
FY2024
Go
Light
System
Dark
/
Medications
›
galcanezumab-gnlm
galcanezumab-gnlm
RxCUI 2058868
precise ingredient
Contraindicated with · 5
Chemically-Induced Disorders
Disease
Diseases, Life Phases, Behavior Mechanisms and Physiologic States
Drug Hypersensitivity
Drug-Related Side Effects and Adverse Reactions
Indicated for · 9
Brain Diseases
Central Nervous System Diseases
Cluster Headache
Disease
Diseases, Life Phases, Behavior Mechanisms and Physiologic States
Headache Disorders
Headache Disorders, Primary
Nervous System Diseases
Trigeminal Autonomic Cephalalgias
Indicated to prevent · 8
Brain Diseases
Central Nervous System Diseases
Disease
Diseases, Life Phases, Behavior Mechanisms and Physiologic States
Headache Disorders
Headache Disorders, Primary
Migraine Disorders
Nervous System Diseases
